Search

everythinglearnresearchcommunity

for

Search:↓

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Adding TERT and BMI1 to certain skin cells can improve their ability to create hair follicles in mice.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Reflectance confocal microscopy helped diagnose and manage a woman's hair loss without needing a biopsy.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Keratin 14 may be an autoantigen in autoimmune skin diseases.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.

BTNL2 helps protect hair follicles from immune attacks.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Retinoic acid can change skin development, like turning scales into feathers or forming glands.

RXR agonists may promote hair growth in humans.

SM04755 may be an effective topical treatment for psoriasis.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

RhoA helps skin stem cells grow, aiding wound healing.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Certain proteins, Lgr5 and Lgr6, are important markers of adult stem cells and are involved in tissue repair and cancer development.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.